Search Clinical Trials
 
By Condition
 
By Location (USA)
 
By Location (Other)
 
By Sponsor
 
Resources
 
Privacy Policy
 
About Us
Disclaimer
Incentive Programs for Female Substance Abusers Who Smoke - 3 Clinical Trials References presented on Clinical Trials Search is not intended to be a substitute for proven healthcare advice, trips or professional assistance by using a real medical. We aren't mDs. Always confer with your physician about Incentive Programs for Female Substance Abusers Who Smoke - 3 conditions. Clinical Trials Search.org is a website devoted to listing clinical research studies in human subjects. Incentive Programs for Female Substance Abusers Who Smoke - 3 Clinical research trials and Incentive Programs for Female Substance Abusers Who Smoke - 3 medical trials take place in hundreds of localities across the U.S.. A clinical trial or clinical study is a research project with human volunteer subjects. Clinical drug trials and pharmaceutical clinical trials usually evaluate the effectualness of new does drugs. The purpose of the studies / projects is to solve specific human health questions. Clinical trials are a popular way for physicians, government agencies, and private sector companies to discover treatments for all sorts of conditions, such as Incentive Programs for Female Substance Abusers Who Smoke - 3. Incentive Programs for Female Substance Abusers Who Smoke - 3 Clinical Trials and other clinical trials permit volunteers to access healthcare treatment choices before they are available to the general public. Some times the subjects recieve professional assistance for without cost, and every now and again they are compensated for their time. Sometimes there is a cost for a Incentive Programs for Female Substance Abusers Who Smoke - 3 clinical trial. Subjects often receive the most expert healthcare possible for their Incentive Programs for Female Substance Abusers Who Smoke - 3 condition. Risks are a reality, nevertheless, and could include additional or frequent dr. calls, healthcare dangers (perhaps life-jeopardising), and/or the treatment being ineffective. Trials are federally governed with stern guidelines to protect clinical trials subjects.

Home > "I" Clinical Trials Conditions > Incentive Programs for Female Substance Abusers Who Smoke - 3

Incentive Programs for Female Substance Abusers Who Smoke - 3



Incentive Programs for Female Substance Abusers Who Smoke - 3

For Condition: Tobacco Use Disorder
Status: Recruiting
Sponsor(s): National Institute on Drug Abuse (NIDA) ,
Synopsis: Incentive Programs for Female Substance Abusers Who Smoke
Details: This study will determine the influence of voucher-based CM on reducing smoking (and other drug) use during pregnancy or in post-partum women with children under 1 year of age living with them, or in non-pregnant females who smoke. We are targeting smoking cessation since cigarette use is so prevalent in our service. We will compare a control group to two different voucher-based contingent-reinforcement procedures: one that targets smoking abstinence alone vs. one that offers additional incentives for negative BAL and urinalysis results.
Eligibility:
Study Type:  Interventional, Active Control
Minimum Age/Maximum Age: 15 Years/
Genders: Female
Protocol Entry Criteria: Inclusion Criteria: - Pregnant and or post-partum with at least one child under 1 year old living with them, or non-pregnant, non-post-partum females or previous participant in this study protocol - At least 15 years of age - Nicotine Dependent as confirmed by DSM-IV checklist - Current cigarette smoker - Breath CO reading of at least 8 ppm at the time of the initial study screening - Current client with the Shields for Families (Shields) treatment programs Exclusion Criteria: - Non-smoker
Total Enrollment: 90

Location and Contact Information:

Overall Study Official:
LeslieAmass,  Principal Investigator,  Los Angeles Treatment Research Center

Shields for Families, Inc. *Recruiting*
Los Angeles,  California,  90061
United States
Recruiting Leslie  Amass 310-479-9330


Additional Information:
Study ID Numbers:  NIDA-13638-3;  R01-13638-3
Study Start Date: January 2002
Record last reviewed: July 2003
Additional information available at: clinicaltrials.gov
Clinicaltrials.gov Reference link: NCT00064922

Other Tobacco Use Disorder Studies:
1. Role of Metabolites in Nicotine Dependence (1) - 1

2. Progesterone Treatment in Female Smokers - 12

3. Smoking Cessation Treatment with Transdermal Nicotine Replacement Therapy - 1

4. The effects of ERT on appetitive behavior and withdrawal in short-term smoking cessation compared to smoking ad lib in postmenopausal female smokers. - 1

5. The effects of ERT on appetitive behavior and withdrawal in short-term smoking cessation in postmenopausal females on transdermal nicotine replacement - 2

Related Studies:

Other Tobacco Use Disorder Clinical Trials
Other California Clinical Trials
Other Los Angeles Clinical Trials

Incentive Programs for Female Substance Abusers Who Smoke - 3
Modify your Search

  Other Tobacco Use Disorder Clinical Trials
  Other California Clinical Trials
  Other Los Angeles Clinical Trials


Warning: include(/var/www/cgi-bin/traxis/counter.php) [function.include]: failed to open stream: No such file or directory in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103

Warning: include() [function.include]: Failed opening '/var/www/cgi-bin/traxis/counter.php' for inclusion (include_path='.:/usr/local/lib/php') in /home/cts/domains/clinicaltrialssearch.org/public_html/index.php on line 103